Printer Friendly
The Free Library
14,504,729 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

St. Jude Medical Announces Launch of EnSite(R) System 5.1 Software and EnSite Verismo(TM) Segmentation Tool; New Capabilities Enhance Speed and Flexibility of Visualization and Navigation During Electrophysiology Procedures.


ST. PAUL, Minn. -- St. Jude Medical St. Jude Medical, Inc. NYSE: STJ is a $2.9 billion global cardiovascular device company, with headquarters in St. Paul, Minnesota, United States. The company sells products in more than 100 countries and has over 20 operations and manufacturing facilities worldwide. , Inc. (NYSE NYSE

See: New York Stock Exchange
:STJ STJ Superior Tribunal de Justica (Brazil)
STJ Supremo Tribunal de Justiça (Portugal)
STJ Superconducting Tunnel Junction
STJ San Giljan (postal locality, Malta) 
) today announced the launch of the EnSite(R) System Version 5.1 Software and the EnSite Verismo ve·ris·mo  
n.
1. Verism.

2. An artistic movement of the late 19th century, originating in Italy and influential especially in grand opera, marked by the use of rural characters and common, everyday themes often treated in a
(TM) Segmentation Tool for use during electrophysiology (EP) procedures. The EnSite(R) System, a computer-based system designed to facilitate procedures to treat irregular heartbeats, was included in St. Jude Medical's acquisition of Endocardial endocardial /en·do·car·di·al/ (-kahr´de-al)
1. situated or occurring within the heart.

2. pertaining to the endocardium.


endocardial

1. situated or occurring within the heart.

2.
 Solutions, Inc. (ESI (Edge Side Includes) A markup language for Web pages that enables elements of a Web page to be dynamically assembled in servers distributed throughout the Internet. ) in January 2005.

"The introduction of EnSite(R) System Version 5.1 is a significant advance in 3-D navigation and visualization technology," said Jane J. Song, President of the St. Jude Medical Atrial Fibrillation atrial fibrillation

Irregular rhythm (arrhythmia) of contraction of the atria (upper heart chambers). The most common major arrhythmia, it may result as a consequence of increased fibrous tissue in the aging heart, of heart disease, or in association with severe infection.
 Division. "Combined with the EnSite Verismo(TM) Segmentation Tool, this upgrade will provide greater clinical value for physicians through increased speed, flexibility and control during procedures. These capabilities are a critical element of effective EP procedures."

The EnSite 5.1 Software features MultiPoint(TM) technology, which is designed to increase the speed and efficiency of cardiac mapping procedures. The EnSite Verismo(TM) Segmentation Tool uses CT (computed tomography Computed tomography (CT scan)
X rays are aimed at slices of the body (by rotating equipment) and results are assembled with a computer to give a three-dimensional picture of a structure.
) and MRI 1. (application) MRI - Magnetic Resonance Imaging.
2. MRI - Measurement Requirements and Interface.
 (magnetic resonance imaging magnetic resonance imaging (MRI), noninvasive diagnostic technique that uses nuclear magnetic resonance to produce cross-sectional images of organs and other internal body structures. ) scans to build 3D cardiac models which assist in procedure planning, geometry creation, and validation of therapy delivery.

Using the EnSite(R) System, electrophysiology clinicians can create 3-dimensional models of their patients' cardiac anatomy during EP procedures and navigate the catheters used in those procedures. The system then collects and organizes activation and voltage data from the inner surface of the heart, allowing physicians to visualize arrhythmias on the 3-D model and determine a treatment strategy.

MultiPoint(TM) technology, a feature unique to EnSite(R) System Version 5.1 Software, enables collection of data from up to 64 electrodes on 12 catheters at one time. This feature can significantly improve procedural efficiency and flexibility, gathering and displaying more information in a shorter period of time. Low-Voltage Identification is another new feature in the software, allowing users to control how voltage data from the inner surface of the cardiac chamber is displayed and helping to validate therapy delivery.

The EnSite Verismo(TM) Segmentation Tool is a new software program that allows clinicians to transform 2-dimensional CT or MRI scans into 3-D models for use with the EnSite(R) System. These models can then be segmented into individual cardiac chambers or vessels, providing highly accurate representations on which to base an EP procedure.

St. Jude Medical, Inc. (www.sjm.com) is dedicated to the design, manufacture and distribution of innovative medical devices of the highest quality, offering physicians, patients and payers outstanding clinical performance and demonstrated economic value.

St. Jude Medical's Atrial Fibrillation business is committed to leadership in the development of curative therapies for atrial fibrillation through innovation technologies, procedures and clinical studies that will result in clinically reproducible and economically compelling treatment options.

Any statements made regarding the Company's anticipated future product launches, regulatory approvals, revenues, earnings, market shares, and potential clinical success are forward-looking statements which are subject to risks and uncertainties, such as those described in the Financial Section of the Company's Annual Report to Shareholders for the fiscal year ended December 31, 2004 (see page 16). Actual results may differ materially from anticipated results.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Sep 28, 2005
Words:516
Previous Article:Worldwide MCU Units Shipped between 2004 and 2009 are Expected to Increase at an Annual CAGR of 10.3.
Next Article:46 Early-Stage Cardiovascular, Spine and Orthopedic, Drug Delivery, Imaging, Neuromodulation and Oncology, Among Other Companies Confirmed to Present...
Topics:



Related Articles
St. Jude Medical to Present Innovative Technologies and Important Clinical Updates at Heart Rhythm 2005.
St. Jude Medical Announces U.S. Launch of New Technology for Placing Guidewires in Coronary Vessels; Venture(TM) Wire Control Catheter Gives...
St. Jude Medical Announces FDA Approval and Market Launch of New Cardiac Ablation Generator and Therapy(TM) Catheters.
St. Jude Medical to Highlight Broad Portfolio of Innovative Medical Technologies at Boston Atrial Fibrillation Symposium.
St. Jude Medical Announces Japanese Approvals of EnSite System; Computer-based Visualization and Navigation Tool Used with Heart Rhythm Patients.
St. Jude Medical Announces European CE Mark of New Products at International Cardiac Meeting.
St. Jude Medical Announces FDA Clearance and European Approval of New Electrophysiology Products.
St. Jude Medical Announces FDA Clearance and European Approvals for Cardiac Mapping and Navigation Software.
St. Jude Medical Announces Expanded European CE Mark to Include Therapy Cool Path Bi-Directional Irrigated Ablation Catheter; U.S. Approval for...
St. Jude Medical Showcases New Product Offerings at Heart Rhythm Society Meeting in Denver.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles